morning welcome idexx laboratory second quarter earn conference call reminder today conference record participate call morning president chief executive officer chief financial officer senior director investor relation idexx would like preface discussion today caution regard forward look statement listener remind discussion call include forward look statement subject risk uncertainty could cause actual result differ materially discuss today additional information regard risk uncertainty available forward look statement notice press release issue morning periodic file security exchange commission obtain visit investor relation section website idexx call discuss certain financial measure prepare accordance generally accept account principle reconciliation financial measure directly comparable measure provide earn release also find visit investor relation section website review second quarter result please note reference growth organic growth comparable growth refer growth compare equivalent period unless otherwise note operator instruction would like turn call executive vice president chief financial morning everyone please take second quarter result provide update full year financial outlook term highlight idexx deliver another quarter outstanding financial result support continue strong global momentum companion animal business revenue increase report organically support organic growth diagnostic recur revenue reflect continue high gain across international region work comparison prior year impact highlight select year average annual revenue growth metric calibrate business trend second quarter average annual year organic growth diagnostic recur revenue line strong year growth trend operate profit increase comparable basis second quarter reflect benefit high revenue growth moderate operate margin gain begin tight control introduce initial stage pandemic high operate profit gain enable delivery earn share increase comparable basis continue strong momentum business track deliver high revenue profit gain raise full year revenue growth outlook range million midpoint billion billion reflect outlook report revenue growth include favorable impact change benefit recent acquisition update full year outlook overall organic revenue growth growth diagnostic recur revenue organic growth range higher last outlook reflect expectation sustain strong performance business globally full year financial outlook reflect target basis point improvement operate margin comparable basis basis point last outlook advance increase investment innovation commercial capability increase outlook share share midpoint reflect full year comparable growth update financial outlook later comment begin review second quarter result recent sector trend second quarter organic revenue growth drive revenue gain growth water business benefit prior year pandemic impact note diagnostic recur revenue increase organically reflect growth growth international region year basis average annual diagnostic recur revenue growth overall reflect gain growth international strong result also support organic growth diagnostic instrument revenue compare constrain prior year level growth diagnostic recur revenue high year year gain clinical business benefit part comparison lower visit level clinical visit growth overall strong gain across nonwellness wellness visit category average year basis store clinical visit growth increase annual rate modestly strong result idexx diagnostic recur revenue growth premium clinical visit approximately basis point second quarter moderately track full year outlook expand healthcare service include continue solid increase utilization diagnostics support store increase overall veterinary clinic revenue diagnostic revenue practice increase year basis average year basis look ahead second half note last call expect lower level year growth clinical visit diagnostic revenue gain significant step demand second half dynamic factor revenue guidance project sustain strong tier growth diagnostic recur revenue idexx innovation commercial initiative continue build positive healthcare demand trend drive high organic revenue gain across major test modality globally idexx global reference revenue increase organically reflect plus organic gain approximately growth international region international reference gain continue benefit strong growth support core capability expand commercial presence growth idexx program agreement global reference gain continue drive high store volume growth strong gain across test category idexx consumable revenue increase organic basis second quarter also reflect continue plus growth approximately organic gain international gain continue support increase test utilization across region high customer retention level expansion global premium instrument base instrument placement increase significantly compare constrain prior year level total premium placement reach unit unit strong result double placement level last year quality instrument placement remain excellent reflect catalyst placement competitive account north year year competitive placement international region also benefit second catalyst placement drive continue strong demand high volume customer placement high customer retention level support year year growth global catalyst base achieve premium hematology placement include hundred install advance global rollout schedule support growth global premium hematology base compare also place include strong placement level international region idexx agreement support year year global increase premium urine sediment base look forward build momentum gain increase direct access veterinary clinic globally support strong demand diagnostic test rapid assay revenue also expand strong organic growth rate reflect plus gain support high demand wellness test accelerate plus growth international geography note core vector bear disease retention rate rapid assay reach quarter align sustain high idexx retention rate across major modality high diagnostic revenue growth remain primarily volume drive across modality consistent overall price gain area business veterinary software diagnostic image revenue increase organically report include initial benefit recent acquisition high growth diagnostic image system placement drive favorable customer response entry level platform approximately placement competitive account also continue plus growth recur digital service revenue include expansion pack subscription align expand cloud base capability veterinary software service business post double digit organic revenue gain drive growth cornerstone placement strong growth recur service expand cloud base software capability recently announce acquisition close estimate contribute approximately million full year revenue factor update outlook turn business segment water business revenue increase organically compare decline last year second quarter drive early pandemic relate impact continue solid recovery demand water test economy reopen include recovery noncompliance relate test volume constrain pandemic livestock poultry dairy revenue decrease organically growth result constrain high prior year demand area swine fever test revenue growth also impact relatively lower herd health screen level reflect reduce export include effect restriction live animal import plan reduce revenue year year second half continue benefit high prior year demand program manage expect pressure business rebuild swine herd port price change government requirement relate livestock infectious disease program turn another quarter strong profit gain drive primarily benefit high year year diagnostic recur revenue gain start work comparison control level prior year implement part pandemic contingency management effort despite dynamic strong revenue growth support solid basis point expansion operate margin comparable basis help drive increase operate profit report comparable basis gross profit increase drive higher revenue gain gross margin decrease modestly comparable basis reflect impact higher instrument revenue moderate gross margin gain tightly control prior year level area operation gross margin gain continue benefit strong diagnostic recur revenue growth include positive impact moderate price gain plan constrain gross margin gain balance year continue tightly control prior year spend level impact increase reference staff capacity align support high revenue growth operate expense increase report comparable basis advance approximately million reduction relate plan level include temporary reduction salary benefit also significant reduction area employee healthcare accrual higher operate expense growth reflect dynamic advancement investment global commercial innovation capability align accelerate revenue growth profile anticipate operate expense growth higher revenue growth second half investment integration acquisition advance also expect relative increase employee healthcare claim travel pandemic relate restriction ease share include benefit million share relate share base compensation activity comparable basis increase foreign exchange million operate profit million hedge loss free cash flow million quarter million first half trail month basis income free cash flow conversion rate include benefit delay capital spend extension payment last year increase outlook full year capital spend million million reflect additional investment support manufacture distribution growth capacity include approximately million real estate purchase higher level project spend update free cash flow conversion outlook full year approximately income balance sheet remain strong position quarter debt leverage ratio time gross time cash million cash borrow billion revolve credit facility allocate million capital repurchase share quarter turn full year outlook increase project range overall revenue billion billion midpoint reflect approximately million organic operational improvement approximately million benefit update assumption approximately million increase full year revenue benefit acquisition update revenue outlook report include approximately full year growth benefit approximately benefit acquisition update overall organic revenue growth outlook reflect estimate organic growth range diagnostic recur revenue high diagnostic recur revenue growth outlook range reflect year average annual growth rate line strong performance level note year growth basis expect moderation high year year growth rate first half year work acceleration comparison acceleration growth second half include fulfillment demand last year third quarter element revenue growth outlook include expectation lower year year revenue second half reduction human test revenue year year benefit prior year initiative plan lower human test level term financial metric increase report operate margin outlook reflect increase expectation basis point full year annual full year comparable operate margin improvement outlook incorporate update projection foreign exchange estimate provide positive full year benefit establish hedge position full year outlook also include update estimate share benefit relate share base compensation activity share higher prior projection provide detail update estimate table press release earn snapshot conclude financial view turn call comment president chief executive officer good morning today please report another quarter strong result support continue favorable trend core business excellent execution idexx note deliver organic revenue growth second quarter support high organic diagnostics recur revenue growth strong gain across business segment test modality represent continuation accelerate growth trend since second half strong sector growth outstanding execution idexx give confidence raise financial outlook continue invest toward significant long term growth opportunity today provide brief update trend region companion animal sector status initiative strengthen international commercial capability also share update launch grow software portfolio include acquisition better position capitalize favorable tailwind enhance practice productivity raise standard patient care start update sector trend global sector trend remain favorable second quarter reflect example sustain high clinical visit model support continue strong increase veterinary service revenue include diagnostics note clinical visit increase quarter year average annual basis continue strong gain across wellness nonwellness category growth support grow population veterinarian focus medical service sustain even pandemic restriction ease solid trend across global region strong commercial execution build momentum reflect idexx diagnostics organic recur revenue growth year basis year average annual basis within clinic veterinarian continue rise challenge increase demand work hard keep industry growth also deliver excellent patient care ever engage parent idexx position provide tool service necessary meet demand support diagnostics revenue growth practice even faster growth idexx revenue overall feel positive strong sector backdrop strategy bring test information management innovation practice level execution reflect raise full year revenue outlook term execution commercial continue deliver exceptional result despite continue constrain clinic access instrument placement show increase momentum second quarter total premium placement solidly strong help drive growth premium worldwide base quarter include double digit growth premium chemistry hematology urinalysis base continue excellent growth competitive account veterinary customer extremely busy high visit volume invest idexx instrument diagnostics tool support practice growth patient care staff productivity digital cytology solution excellent example point innovative service extend capability reach practice provide cytology test result report author expert another hour time week year veterinarian able provide higher standard care patient improve staff clinical productivity drive appropriate test practice revenue validate medical value proposition strong customer interest order digital cytology solution also continue advance program like idexx preventive care help clinic raise standard care align higher level owner engagement execute preventive care enrollment continue advance toward goal engage customer term customer access continue operate hybrid model access still limit improve international region approximately customer visit person whereas approximately impact ability deliver outstanding result innovation excellent relationship customer drive significant growth across region deep customer relationship sale professional reinforce strengthen best class support provide customer throughout pandemic note particularly please high level execution region like expand successful market approach apply reflect catalyst placement competitive account outside north half placement idexx agreement expansion idexx program also support sustain strong gain revenue accelerate account acquisition help inspire faster customer growth idexx customer focus strategy context develop long term international revenue opportunity expansion direct commercial presence complete commercial expansion first announce last year focus three country south almost double commercial footprint country appreciably increase frequency intensity call activity exist customer competitive account experience customer grow faster adopt innovation three additional country target next stage expansion remainder excite share broader commercial approach upcoming investor expand global commercial capability support adoption innovation like follow first shipment late march international launch begin installation presale customer southern many international geography hematology focus mean customer prioritize patient health assessment surprisingly extremely positive reaction introduction international region customer apply simplicity small footprint still deliver excellent accuracy usability reliability profile veterinarian staff price highly additionally expect multiplier impact chemistry hematology test hand hand additional potential inspire reference rapid assay business place part idexx program speak rapid assay please strong momentum continue drive business globally achieve plus organic growth raise customer retention level support innovation like snap snap customer volume engage platform enhance insight support practice workflow snap also help achieve accelerate growth international region clinic first snap significant expansion test volume look forward build strong momentum support continue idexx innovation also excite progress advance cloud base software capability another excellent quarter software installation cornerstone placement grow cloud base offer continue represent majority placement continue expand base also continue drive expansion profitable recur service credit card process grow strong double digit rate organically software solution take significant importance effective management veterinary practice practice never busier idexx integrate easy software solution support patient care workflow staff productivity communication among care client idexx diagnostic solution seamlessly integrate third party solution enable practice capture invoice full range activity veterinarian deliver know idexx customer solution higher customer experience tend test grow faster relate grow importance practice software solution cloud base technology potential make important contribution overall software experience veterinary clinic example practice owner free challenge support premise solution include frequent hardware update provider cloud base solution like idexx provide frequent seamless update environment offer security advantage software capability augment acquisition grow innovative practice information management system native cloud base advance general practice specialty emergency large corporate group worldwide acquisition complement portfolio provide additional option practice complex need enterprise functionality customer appreciate software easy rich feature fact number full feature practice management solution customer satisfaction industry standard business software customer review site bring idexx family also grow cloud development talent enable capitalize evolve nature veterinary clinic software product like welcome idexx look forward work together continue develop best class software product also excite progress drive diagnostic image business strong growth digital image placement strong growth backlog reflect continue appreciation focus provide full range premier dose image solution growth placement also support expansion recur service include cloud base service like subscription grow high teen rate much faster growth premium unlimited subscription tier reflect high value diagnostic insight clinician drive idexx software solution overall please business momentum optimistic continue respond reopen economy globally term idexx specific plan excite advance plan bring idexx back office safely ensure business continuity anticipate maintain hybrid work environment appreciate employee flexibility adapt work continue deliver high growth provide notch customer service support world class product portfolio wrap remark like publicly welcome leader idexx join leadership executive vice president chief technology officer bring plus year experience life science industry recently chief technology officer corporation subsidiary danaher strong track record drive strategy concert enterprise strategic initiative commercial effort look forward lead world class organization welcome like extremely proud entire idexx execute track another strong year financial performance align long term goal growth performance reflect consistent business strategy focus opportunity development within core business employee continue execute strategy daily look forward share strategy long term potential upcoming investor event remain virtual evolve nature invite register investor relation section website participate member senior management include executive vice president hunt executive vice president general manager point care diagnostics worldwide operation lane executive vice president reference laboratory information management executive vice president chief commercial officer senior vice president corporate strategy advance analytics senior vice president veterinary software service event last approximately three hour conclude session conclude open remark time question